Integra LifeSciences Holdings Corporation

Financials

İşletme faaliyetlerinden elde edilen nakit 50.74 M-11.26 M8.92 M40.91 M11.82 M 50.38 M Yatırım faaliyetlerinden elde edilen nakit -4.25 M-35.92 M-21.65 M-15.59 M-34.91 M -108.06 M Finansman faaliyetlerinden elde edilen nakit -7.15 M35.38 M-21.14 M-10.24 M24.34 M 28.34 M Free cash flow 21.14 M-40.18 M-11.23 M25.75 M-5.4 M -31.05 M

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.

IART

Financials

Integra LifeSciences Holdings Corporation

Haberler

Neuronetics, Dan Reuvers’i 23 Mart’ta CEO olarak atadı

Should You Continue to Hold Integra Stock in Your Portfolio Now?

Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up

Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term

Integra 4Ç 2025: Marj baskısı ilerlemeyi gölgede bıraktı

Integra Q4 2025 slides: mixed results as margin pressure offsets progress

Integra (IART) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates

Integra kazancı $0,03 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Integra LifeSciences tahminleri aştı ancak beklentilerin altında rehberlik verdi

Integra LifeSciences beats estimates but guides below consensus

Integra LifeSciences yeni CTO ve kilit yöneticiler atadı